AHN-GOOK PHARMACEUTICAL Co., Ltd. Q3 operating profit KRW 10.0 billion, up 104.1% from a year earlier
AI summary · Not investment advice
Anguk Pharmaceutical sold KRW 97.2 billion in Q3 and earned KRW 10.0 billion from its main business, up 104.1% from a year earlier and 15.3% from the prior quarter.
Operating profit · 3 months
KRW 10.0 billion
Key facts
- Revenue (3 months)
- KRW 97.2 billion
- Net income (3 months)
- KRW 5.8 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 77.7 billion
- Revenue (year to date)
- KRW 288.0 billion
- Operating profit (prior-year 3 months)
- KRW 4.9 billion
- Operating profit (year to date)
- KRW 34.6 billion
- Net income (prior-year 3 months)
- KRW 3.4 billion
- Net income (year to date)
- KRW 26.8 billion
Commentary
AI commentary · Not investment advice
What happened
Anguk Pharmaceutical reported its consolidated results for the third quarter of 2026.
In the company's terms
Revenue for the 3 months was KRW 97.2 billion. That is 25.1% higher than the same 3 months a year earlier, and 5.8% higher than the previous quarter.
What changes for shareholders
Operating profit (profit from the core business) for the 3 months was KRW 9.97 billion. That is 104.1% higher than a year earlier, and 15.3% higher than the previous quarter.
Net income (final profit after taxes and all other costs) for the 3 months was KRW 5.85 billion. That is 74.1% higher than a year earlier, and 31.8% lower than the previous quarter.
For the year to date (Jan 1 to Sep 30), revenue was KRW 288.0 billion. Operating profit was KRW 34.63 billion, and net income was KRW 26.82 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
A